Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB) [NA]

View source ↗

Summary

Status update on a feasibility study evaluating the Juveena Hydrogel System for heavy menstrual bleeding; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Juveena Hydrogel System

Snippet

Sponsor: Rejoni Inc. | Conditions: Heavy Menstrual Bleeding | NA | Status: RECRUITING